Changmin Sung

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Recombinant Human

Mass Spectrometry

Pluripotent Stem Cells

Top Venues

Drug testing and analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Joon-Yeop Yi, Minyoung Kim, Mijin Jeon, Hophil Min, Byung-Gee Kim, Junghyun John Son, Changmin Sung
Simple Visualization Method for the c.577del of Erythropoietin Variant: CRISPR/dCas9 based Single Nucleotide Polymorphism Diagnosis. Drug testing and analysis (2023)
Joon-Yeop Yi, Minyoung Kim, Mijin Jeon, Hophil Min, Byung-Gee Kim, Junghyun John Son, Changmin Sung
Simple visualization method for the c.577del of erythropoietin variant: CRISPR/dCas9-based single nucleotide polymorphism diagnosis. Drug testing and analysis (2023)
Jaehoon Jung, Yujin Jeong, Yinglan Xu, Joonyeop Yi, Minyoung Kim, Hee-Jin Jeong, Sang Hoon Shin, Yung-Hun Yang, Junghyun John Son, Changmin Sung
Production and engineering of nanobody-based quenchbody sensors for detecting recombinant human growth hormone and its isoforms. Drug testing and analysis (2023)
Joon-Yeop Yi, Minyoung Kim, Hophil Min, Byung-Gee Kim, Junghyun John Son, Oh-Seung Kwon, Changmin Sung
New application of the CRISPR-Cas9 system for site-specific exogenous gene doping analysis. Drug testing and analysis 13 (4) (2021)
Yoondam Seo, Jisoo Park, Minyoung Kim, Changmin Sung, Oh-Seung Kwon, Hwa Jeong Lee, Hophil Min
Optimization, validation, and comparison of a rapid method for the quantification of insulin-like growth factor 1 in serum using liquid chromatography-high-resolution mass spectrometry. Drug testing and analysis 13 (2) (2020)